tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

FOXO Technologies Announces Spin-Off of FOXO Labs

Story Highlights
  • FOXO Technologies plans to spin off its epigenetics-focused subsidiary, FOXO Labs.
  • The spin-off aims to enhance business strategy and shareholder value with a new revenue model.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
FOXO Technologies Announces Spin-Off of FOXO Labs

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

FOXO Technologies ( (FOXO) ) has shared an update.

On July 18, 2025, FOXO Technologies Inc. announced its Board of Directors’ decision to pursue the spin-off of its subsidiary, FOXO Labs, Inc., which focuses on epigenetics. This move aims to enhance the company’s business strategy by creating a subscription-based revenue model for personal health and longevity, potentially increasing value for shareholders and simplifying business models for both FOXO Technologies and the newly independent FOXO Labs.

Spark’s Take on FOXO Stock

According to Spark, TipRanks’ AI Analyst, FOXO is a Underperform.

FOXO Technologies receives a low overall stock score primarily due to significant financial challenges, including continuous net losses, high debt, and negative cash flows. The technical analysis also suggests bearish momentum. Although valuation metrics are poor, recent corporate actions, such as acquisitions and restructuring, provide some hope for future improvement. However, these are not sufficient to outweigh the current financial and operational challenges facing the company.

To see Spark’s full report on FOXO stock, click here.

More about FOXO Technologies

FOXO Technologies Inc. operates in the biotechnology industry, focusing on improving human health and lifespan through advanced technology and product solutions. The company owns and operates subsidiaries including FOXO Labs, Inc., which specializes in epigenetic biomarker development, and other healthcare facilities in East Tennessee.

Average Trading Volume: 7,314,504

Technical Sentiment Signal: Sell

Current Market Cap: $2.71M

See more data about FOXO stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1